- ongoing, recruitingTherapeutic confirmatory (Phase III)
A 104-WEEK, MULTICENTER, SINGLE-ARM, LONG-TERM, PHASE 3 EXTENSION TRIAL INVESTIGATING THE SAFETY AND EFFICACY OF GLEPAGLUTIDE IN ADULT PATIENTS WITH SHORT BOWEL SYNDROME (SBS) COMPLETING THE EASE SBS 2 TRIAL
This study looks at a new medicine called glepaglutide for adults with short bowel syndrome. It checks how safe and effective it is over a long time, especially what side effects people might have and if it helps reduce their need for IV feeding.
Denmark · Belgium · Germany - ongoing, recruitingTherapeutic confirmatory (Phase III)
A DOUBLE-BLIND PHASE 3 EXTENSION TRIAL ASSESSING THE LONG TERM SAFETY AND EFFICACY OF GLEPAGLUTIDE IN PATIENTS WITH SHORT BOWEL SYNDROME (SBS)
This study is looking at a new medicine called glepaglutide for people with Short Bowel Syndrome. It wants to see how safe and effective it is over a long time. Researchers will compare glepaglutide to a dummy medicine to see if it helps reduce the need for intravenous feeding.
France · Belgium · Germany - active not recruitingPHASE3
Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS
This study is looking long-term at a new medicine called glepaglutide for people with Short Bowel Syndrome (SBS). It checks how safe it is and how well it helps manage the condition over time. The study aims to improve care for SBS patients.
United States · Belgium · Canada - active not recruitingPHASE3
Open-label Extension Trial to Evaluate the Long-term Safety of Apraglutide in Short Bowel Syndrome.
This study looks at the long-term safety of a treatment called apraglutide for people with Short Bowel Syndrome. It's for those who were in previous studies, checking if the treatment is safe and tolerable over a longer period.
United States · Argentina · Belgium - active not recruitingPHASE3
Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS - Extension Trial
This study looks at a medicine called glepaglutide for people with Short Bowel Syndrome. It's an extension of a previous trial, checking if the medicine remains safe and effective over a longer time, specifically about two years.
United States · Belgium · Denmark - recruitingPHASE2
Phase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF Subjects
This study looks at a new medicine, HM15912, for adults with Short Bowel Syndrome. We want to see if it's safe, how it works in the body, and if it could help. Participants will receive either the new medicine or a dummy medicine.
United States · Belgium · Denmark - recruiting
SBS DISK- Creation of a Quality of Life Tool for Short Bowel Patients Compared With a Validated Quality of Life Questionnaire (SBS QoL)
This study is creating a simpler way to check how short bowel syndrome affects daily life for adults in France. It aims to develop a new tool that's quicker and easier to use than existing questionnaires, helping doctors better understand patients' well-being.
France